Please login to the form below

Not currently logged in
Email:
Password:

factor X concentrate

This page shows the latest factor X concentrate news and features for those working in and with pharma, biotech and healthcare.

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex

The panel backed Coagudex (factor X concentrate) from Bio Products Laboratory for the treatment of factor X deficiency, a rare inherited bleeding disorder, along with Actelion's Uptravi (selexipag) for pulmonary ... deficiency. The product works as

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics